Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Refractory Ewing Sarcoma · Relapsed Ewing Sarcoma · Ewing Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Children's Hospital of Los Angeles, Los Angeles, California, United States

  • Lucile Packard Children's Hospital, Palo Alto, California, United States

  • Children's National Hospital, Washington D.C., District of Columbia, United States

  • Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States

  • Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta, Georgia, United States

  • Johns Hopkins University, Baltimore, Maryland, United States

  • Corewell Health, Grand Rapids, Michigan, United States

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

  • Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

  • Nationwide Children's Hospital, Columbus, Ohio, United States

  • Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

  • St. Jude Children's Research Hospital, Memphis, Tennessee, United States

  • Children's Health Dallas, Dallas, Texas, United States

  • The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • The Hospital for Sick Children, Toronto, Ontario, Canada

Study leads
  • Jazz Study Director

    Study Director

    Jazz Pharmaceuticals